Shares of cbdMD, Inc. (NYSEAMERICAN:YCBD – Get Free Report) fell 2.5% on Friday . The stock traded as low as $0.94 and last traded at $0.96. 58,679 shares were traded during mid-day trading, a decline of 42% from the average session volume of 101,617 shares. The stock had previously closed at $0.98.
Wall Street Analysts Forecast Growth
Separately, Maxim Group lowered their price objective on cbdMD from $16.00 to $3.00 and set a “buy” rating for the company in a research report on Thursday, May 22nd.
Check Out Our Latest Stock Report on cbdMD
cbdMD Stock Down 2.5%
About cbdMD
cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.
Featured Articles
- Five stocks we like better than cbdMD
- How to trade penny stocks: A step-by-step guide
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
- How to Buy Cheap Stocks Step by Step
- 3 Oversold Stocks Flashing Bullish Reversal Signals
- Short Selling – The Pros and Cons
- With Novo Nordisk’s CEO Out, Wall Street Wants an American Leader
Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.
